NASDAQ:CDMO
Avid Bioservices Inc. Stock News
$9.20
-0.0500 (-0.541%)
At Close: May 16, 2024
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
11:58pm, Wednesday, 06'th Mar 2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing o
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
04:32pm, Wednesday, 06'th Mar 2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it inten
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
04:31pm, Wednesday, 06'th Mar 2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient li
Avid Bioservices: Don't Miss The Bigger Picture
02:58am, Sunday, 07'th Jan 2024
Avid Bioservices has invested heavily in building new facilities, causing lower margins and negative free cash flow. The company's recent expansion projects have increased its revenue capacity to $400
Why Is Avid Bioservices (CDMO) Stock Down 18% Today?
09:35am, Friday, 08'th Dec 2023
Avid Bioservices (NASDAQ: CDMO ) stock is falling on Friday following the release of its earnings report for its fiscal second quarter of 2024. Avid Bioservices reported adjusted earnings per share o
CDMO Stock Earnings: Avid Bioservices Misses EPS, Misses Revenue for Q2 2024
09:54pm, Thursday, 07'th Dec 2023
Avid Bioservices (NASDAQ: CDMO ) just reported results for the second quarter of 2024. Avid Bioservices reported earnings per share of -12 cents.
Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call Transcript
09:44pm, Thursday, 07'th Dec 2023
Avid Bioservices, Inc. (NASDAQ:CDMO ) Q2 2024 Earnings Conference Call December 7, 2023 4:30 PM ET Company Participants Tim Brons - Investors Relations Group Nick Green - President and CEO Dan Hart -
Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
06:48pm, Thursday, 07'th Dec 2023
Avid Bioservices (CDMO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.01 per share a year ago.
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
04:05pm, Thursday, 30'th Nov 2023
TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient live
Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
11:17am, Tuesday, 28'th Nov 2023
Avid Bioservices (CDMO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es
From laggards to leaders: Small caps on the rise
08:45am, Monday, 27'th Nov 2023
Stocks driving that large-cap index performance include names you've become familiar with this year, such as Nvidia Corp. NASDAQ: NVDA, Tesla Inc. NASDAQ: TSLA and Meta Platforms Inc. NASDAQ: META, bu
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?
05:16am, Wednesday, 15'th Nov 2023
Avid Bioservices (CDMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
Avid Bioservices, Inc. (CDMO) Q1 2024 Earnings Call Transcript
10:03pm, Thursday, 07'th Sep 2023
Avid Bioservices, Inc. (NASDAQ:CDMO ) Q1 2024 Earnings Conference Call September 7, 2023 4:30 PM ET Company Participants Tim Brons - Investor Relations Nick Green - President & Chief Executive Officer
Avid Bioservices (CDMO) Reports Break-Even Earnings for Q1
06:47pm, Thursday, 07'th Sep 2023
Avid Bioservices (CDMO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023
04:05pm, Thursday, 31'st Aug 2023
TUSTIN, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient live